H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
about
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerMolecular Aspects of Head and Neck Cancer TherapyAberrant expression of cyclin A and cyclin B1 proteins in oral carcinomaHRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes.Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell CancerHuman papillomavirus and disease mechanisms: relevance to oral and cervical cancers.Mouse models for human head and neck squamous cell carcinomas.The molecular pathogenesis of head and neck squamous cell carcinomaHuman papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.Verrucous carcinoma of the head and neck - not a human papillomavirus-related tumour?The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistanceSignaling pathways in HPV-associated cancers and therapeutic implications.New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma.Signature of genetic associations in oral cancer.The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.Morphological Assessment of Malignant Potential of Epithelial Hyperplastic Lesions
P2860
Q26852215-CABE4B0F-D7FB-4A7E-A463-5D5B4A53E046Q28082815-F98B4A05-6CCF-4BA2-9AD8-6B38D466C9B0Q28296721-04247BD6-4288-4028-8631-3D6EA06DAFB9Q33568344-7FFDAF79-110E-4724-8DB5-347E999CE698Q34049613-7C2F03BA-3CF7-4093-A289-086D8A967FA4Q34249547-B1C216E7-461C-4C67-ADAB-3FF1DEC13076Q34286359-5FF63A09-2401-429A-AB2E-274BBB6C61DBQ34330763-0CD54DC3-4E98-4903-BB25-52357468B7F3Q34653637-3247BEF9-602F-4B00-A143-1CFEEE1AE3B0Q35009672-274E6740-F2C1-4BE3-AA52-099E40BB7CD9Q35875753-2FB60474-E7E8-4542-8464-08C0434D7BC0Q36305948-D8A5B924-D9D1-46EC-87E9-650CFDDBF57FQ36487799-F1A59B79-FC8B-418B-8980-52EEE35E2A79Q36659339-D08BEA07-3332-4FF8-AF8D-B88E131E527FQ36806481-002992CB-6B93-4CBA-B21C-E9AB005FF589Q37039386-1AC2AFAB-1057-465C-81A1-F82EB0783F52Q37690668-2A34F1C0-F034-476D-9E1F-CA4F1EF6B399Q37724026-3A8CBB6C-04D1-4441-BA3E-39F8B9BD66E7Q38067674-85F0F1E6-8616-4360-A8C9-E1D973FDC04AQ38118934-5D13DC1A-4A5A-4DBC-8AE4-7C402FEB1EB8Q38370778-C595BC4A-B7ED-40B4-A64E-2812022874A2Q41127315-CE3924C8-67F2-4D7F-9C79-78F69D739677Q42545098-0B1FB5B8-08A3-4F87-938A-31F9C822E47BQ45757410-DA597B07-B8E9-4970-BD61-B3F93CAF2429Q50075658-85C83E61-7692-471D-8821-B9BEF72FB4E3Q53207023-822488DA-685F-460E-8237-1B86CEFCFD4EQ58081467-278E8C3D-3EAD-46C9-A401-BCCC3F9E8985
P2860
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@en
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@nl
type
label
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@en
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@nl
prefLabel
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@en
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@nl
P2093
P1433
P1476
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
@en
P2093
P304
P356
10.1001/ARCHOTOL.1994.01880310059011
P577
1994-07-01T00:00:00Z